
Hematology-Oncologyvenetoclax resistanceCitrate Metabolism
IDH3 as a Metabolic Checkpoint Modulating Venetoclax Resistance in AML Stem Cells
By MedXY|Sep 27, 2026
This article elucidates how the TCA cycle enzyme IDH3 critically regulates metabolic fitness in AML stem cells, influencing venetoclax resistance and offering a novel target to improve therapeutic outcomes.